"This study was conducted under a contract from the Centers for Medicare and Medicaid (CMS) that had two aims: (1) describe the best practices from 11 demonstration health plans operating in three states and offering comprehensive managed care to dual-eligible beneficiaries (eligible for both Medicare and Medicaid), and (2) assess the impact of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the MMA) on these plans and their members. A separate report dealt with the first aim (Bishop, Leutz et al. 2006), and this report addresses the second, with particular focus on MMA impacts in three areas: finances/the bidding process, marketing, and prescription drugs."--p. 3.

Log in to favorite or list